Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Tablets 90 X 0.5 mg |
|
84066 | 18419 |
|
Tablets 90 X 1 mg |
|
84067 | 18420 |
|
Tablets 90 X 2 mg |
|
84068 | 18421 |
Related information
Dosage
The usual starting dose is 0.5 mg before each main meal.
Swallow the tablets with a glass of water immediately before or up to 30 minutes before each main meal.
Your doctor will adjust your dose, up to 4 mg, to be taken immediately before or up to 30 minutes before each main meal.
The maximum recommended daily dose is 16 mg.
See prescribing information for full details.
Indications
Type 2 diabetes (Non Insulin-Dependent Diabetes Mellitus (NIDDM)) in patients whose hyperglycemia can no longer be controlled satisfactorily by diet, weight reduction and exercise.
Also indicated in combination with metformin in Type 2 diabetes patients who are not satisfactorily controlled on metformin alone.
Treatment should be initiated as an adjunct to diet and exercise to lower the blood glucose in relation to meals.
Contra-Indications
Known hypersensitivity to the active ingredient, or to any other ingredient of the preparation.
Type 1 diabetes (Insulin-Dependent Diabetes Mellitus: IDDM), C-peptide negative.
Diabetic ketoacidosis, with or without coma.
Pregnancy and lactation.
Severe hepatic function disorder.
Concomitant use with gemfibrozil (concomitant use may prolong the effects of repaglinide).
